Tag Archives: CD79b

28Dec/22

ADC Panoramic Overview- Endocytosis of ADC Targeting Antigens

December 28, 2022ReviewADC Targeting Antigens, CD79b, HER2, Trop-2bioadc

CD33 CD33, a 67kda transmembrane glycoprotein receptor, is usually expressed in normal myeloid cells and it is the target of GO because it is preferentially overexpressed in AML cells. The intracellular immunoreceptorRead More…

08Mar/19

ADC-Polatuzumab Vedotin targeting CD79b has been prioritized by FDA in the United States

March 8, 2019Antibody-drug Conjugates Research, NewsADC, CD79b, fda, Polatuzumab Vedotinbioadc

Roche recently announced that the Food and Drug Administration (FDA) has accepted the biological product licensing application (BLA) of the antibody drug conjugate (ADC) Polatuzumab Vedotin and granted priority review qualifications forRead More…

Home
Antibody-drug Conjugates Research
Antibody-drug Conjugates Manufacturing
News